Effects of Pre-, Pro- & Anti-biotics on Gut Microbiota

Human Gut Microbiota Clinical Trial

Official title:
Effects of Mushroom Extract, S Boulardii and Amoxicillin on the Human Microbiome

Status Completed

Clinical Trial Summary

The purpose of this study is to compare and contrast the effects of a prebiotic (Trametes Versicolor), a probiotic (Saccharomyces boulardii) and an antibiotic (amoxicillin) on the gut microbiota of healthy volunteers. It is expected that treatment will result in the rapid and reproducible alterations in fecal microbiota that will spontaneously reverse in the weeks after treatment is discontinued.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science

Related Conditions & MeSH terms

Human Gut Microbiota

Clinical Trial Details

NCT number	NCT01414010
Study type	Interventional
Source	Beth Israel Deaconess Medical Center
Contact
Status	Completed
Phase	N/A
Start date	August 2011
Completion date	February 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02291328` - Effects of Brassica on Human Gut Lactobacilli	N/A
Recruiting	`NCT03080532` - Diet Interactions With Human Gut Microbiota. The Potential Role of Mediterranean Diet Adherence. DIAGRAM, a Pilot Study	N/A
Enrolling by invitation	`NCT02653001` - The QIB Colon Model	N/A